Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity

Biological Psychiatry

Volumn 70, Issue 8, 2011, Pages 744-753

  Potter, David N ^a   Damez Werno, Diane ^a   Carlezon Jr , William A ^a   Cohen, Bruce M ^a   Chartoff, Elena H ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

c Fos; cocaine; CREB; dynorphin; intracranial self stimulation; opponent process

Indexed keywords

COCAINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NORBINALTORPHIMINE; PROTEIN C FOS; SALVINORIN A;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG SENSITIVITY; ENZYME ACTIVATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REWARD; SELF STIMULATION;

ANIMALS; COCAINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DITERPENES, CLERODANE; DRUG INTERACTIONS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; NALTREXONE; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; REWARD; SELF STIMULATION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 80053562267     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.05.021     Document Type: Article

References (62)

1. A. Markou, T.R. Kosten, and G.F. Koob Neurobiological similarities in depression and drug dependence: A self-medication hypothesis Neuropsychopharmacology 18 1998 135 174 (Pubitemid 28062580)
2. R.C. Kessler The effects of stressful life events on depression Annu Rev Psychol 48 1997 191 214 (Pubitemid 127485175)
3. G.F. Koob, and M. Le Moal Drug addiction, dysregulation of reward, and allostasis Neuropsychopharmacology 24 2001 97 129
4. L. Lu, J.D. Shepard, S.F. Hall, and Y. Shaham Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: A review Neurosci Biobehav Rev 27 2003 457 491 (Pubitemid 37162553)
5. J.A. Hollander, H.I. Im, A.L. Amelio, J. Kocerha, P. Bali, and Q. Lu Striatal microRNA controls cocaine intake through CREB signalling Nature 466 2010 197 202
6. C. Konradi, R.L. Cole, S. Heckers, and S.E. Hyman Amphetamine regulates gene expression in rat striatum via transcription factor CREB J Neurosci 14 1994 5623 5634 (Pubitemid 24279078)
7. J.W. Muschamp, A. Van't Veer, A. Parsegian, M.S. Gallo, M. Chen, and R.L. Neve Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats J Neurosci 31 2011 3095 3103
8. R.L. Cole, C. Konradi, J. Douglass, and S.E. Hyman Neuronal adaptation to amphetamine and dopamine: Molecular mechanisms of prodynorphin gene regulation in rat striatum Neuron 14 1995 813 823
9. E.H. Chartoff, M. Papadopoulou, M.L. MacDonald, A. Parsegian, D. Potter, C. Konradi, and W.A. Carlezon Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue Mol Pharmacol 75 2009 704 712
10. C. Chavkin, I.F. James, and A. Goldstein Dynorphin is a specific endogenous ligand of the kappa opioid receptor Science 215 1982 413 415 (Pubitemid 12132127)
11. B.B. Land, M.R. Bruchas, J.C. Lemos, M. Xu, E.J. Melief, and C. Chavkin The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system J Neurosci 28 2008 407 414
12. Y.L. Hurd, and M. Herkenham Molecular alterations in the neostriatum of human cocaine addicts Synapse 13 1993 357 369 (Pubitemid 23104541)
13. T.S. Shippenberg, A. Zapata, and V.I. Chefer Dynorphin and the pathophysiology of drug addiction Pharmacol Ther 116 2007 306 321 (Pubitemid 47454747)
14. A.M. Pliakas, R.R. Carlson, R.L. Neve, C. Konradi, E.J. Nestler, and W.A. Carlezon Jr Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens J Neurosci 21 2001 7397 7403 (Pubitemid 32846987)
15. M.S. Todtenkopf, J.F. Marcus, P.S. Portoghese, and W.A. Carlezon Jr Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats Psychopharmacol Berl 172 2004 463 470 (Pubitemid 38650984)
16. R. Bals-Kubik, A. Ableitner, A. Herz, and T.S. Shippenberg Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats J Pharmacol Exp Ther 264 1993 489 495 (Pubitemid 23309241)
17. W.A. Carlezon Jr, J. Thome, V.G. Olson, S.B. Lane-Ladd, E.S. Brodkin, and N. Hiroi Regulation of cocaine reward by CREB Science 282 1998 2272 2275 (Pubitemid 29004079)
18. T.S. Shippenberg, A. LeFevour, and C. Heidbreder Kappa-opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine J Pharmacol Exp Ther 276 1996 545 554
19. H.C. Tomasiewicz, M.S. Todtenkopf, E.H. Chartoff, B.M. Cohen, and W.A. Carlezon Jr The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward Biol Psychiatry 64 2008 982 988
20. S. Schenk, B. Partridge, and T.S. Shippenberg U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking Psychopharmacology (Berl) 144 1999 339 346 (Pubitemid 29307258)
21. S.S. Negus, N.K. Mello, P.S. Portoghese, and C.E. Lin Effects of kappa opioids on cocaine self-administration by rhesus monkeys J Pharmacol Exp Ther 282 1997 44 55 (Pubitemid 27425525)
22. E.H. Chartoff, D. Potter, D. Damez-Werno, B.M. Cohen, and W.A. Carlezon Jr Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats Neuropsychopharmacology 33 2008 2676 2687
23. C.A. Heidbreder, S. Schenk, B. Partridge, and T.S. Shippenberg Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist Synapse 30 1998 255 262 (Pubitemid 28447173)
24. J.P. McLaughlin, B.B. Land, S. Li, J.E. Pintar, and C. Chavkin Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning Neuropsychopharmacology 31 2006 787 794
25. A.G. Schindler, S. Li, and C. Chavkin Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms Neuropsychopharmacology 35 2010 1932 1942
26. S.S. Negus Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys Psychopharmacol Berl 176 2004 204 213
27. A.N. Carey, K. Borozny, J.V. Aldrich, and J.P. McLaughlin Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn Eur J Pharmacol 569 2007 84 89 (Pubitemid 47175877)
28. J.A. Fuentealba, K. Gysling, K. Magendzo, and M.E. Andres Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens J Neurosci Res 84 2006 450 459 (Pubitemid 44126298)
29. M.R. Bruchas, B.B. Land, and C. Chavkin The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors Brain Res 1314 2010 44 55
30. W.A. Carlezon Jr, and E.H. Chartoff Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation Nat Protoc 2 2007 2987 2995
31. B.L. Roth, K. Baner, R. Westkaemper, D. Siebert, K.C. Rice, and S. Steinberg Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist Proc Natl Acad Sci U S A 99 2002 11934 11939 (Pubitemid 34994502)
32. E.B. Margolis, G.O. Hjelmstad, A. Bonci, and H.L. Fields Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons J Neurosci 23 2003 9981 9986 (Pubitemid 37392543)
33. A.L. Svingos, E.E. Colago, and V.M. Pickel Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell J Neurosci 19 1999 1804 1813 (Pubitemid 29094196)
34. B.B. Land, M.R. Bruchas, S. Schattauer, W.J. Giardino, M. Aita, and D. Messinger Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking Proc Natl Acad Sci U S A 106 2009 19168 19173
35. S.R. Ebner, M.F. Roitman, D.N. Potter, A.B. Rachlin, and E.H. Chartoff Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens Psychopharmacol Berl 210 2010 241 252
36. M.R. Bruchas, M. Xu, and C. Chavkin Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2 Neuroreport 19 2008 1417 1422
37. L.O. Murphy, and J. Blenis MAPK signal specificity: The right place at the right time Trends Biochem Sci 31 2006 268 275 (Pubitemid 43674354)
38. E. Valjent, J.C. Corvol, C. Pages, M.J. Besson, R. Maldonado, and J. Caboche Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties J Neurosci 20 2000 8701 8709
39. L. Lu, B.T. Hope, J. Dempsey, S.Y. Liu, J.M. Bossert, and Y. Shaham Central amygdala ERK signaling pathway is critical to incubation of cocaine craving Nat Neurosci 8 2005 212 219 (Pubitemid 40194052)
40. D.Y. Lee, V.V. Karnati, M. He, L.Y. Liu-Chen, L. Kondaveti, and Z. Ma Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues Bioorg Med Chem Lett 15 2005 3744 3747 (Pubitemid 41038970)
41. C. Beguin, D.N. Potter, J.A. Dinieri, T.A. Munro, M.R. Richards, and T.A. Paine N-methylacetamide analog of salvinorin A: A highly potent and selective kappa-opioid receptor agonist with oral efficacy J Pharmacol Exp Ther 324 2008 188 195 (Pubitemid 350294142)
42. W.A. Carlezon Jr, C. Bguin, A.T. Knoll, and B.M. Cohen Kappa-opioid ligands in the study and treatment of mood disorders Pharmacol Ther 123 2009 334 343
43. E.H. Chartoff, S.D. Mague, M.F. Barhight, A.M. Smith, and W.A. Carlezon Jr Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal J Neurosci 26 2006 6450 6457 (Pubitemid 44318325)
44. A.M. Graybiel Neurotransmitters and neuromodulators in the basal ganglia Trends Neurosci 13 1990 244 254 (Pubitemid 20193453)
45. S. Berretta, H.B. Parthasarathy, and A.M. Graybiel Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum J Neurosci 17 1997 4752 4763 (Pubitemid 27246932)
46. P. Horan, J. Taylor, H.I. Yamamura, and F. Porreca Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test J Pharmacol Exp Ther 260 1992 1237 1243
47. D. Braida, V. Limonta, V. Capurro, P. Fadda, T. Rubino, and P. Mascia Involvement of kappa-opioid and endocannabinoid system on salvinorin A-induced reward Biol Psychiatry 63 2008 286 292
48. T. Endoh, H. Matsuura, C. Tanaka, and H. Nagase Nor-binaltorphimine: A potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo Arch Int Pharmacodyn Ther 316 1992 30 42
49. W.A. Carlezon Jr, C. Beguin, J.A. Dinieri, M.H. Baumann, M.R. Richards, and M.S. Todtenkopf Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats J Pharmacol Exp Ther 316 2006 440 447 (Pubitemid 41832624)
50. A.T. Knoll, and W.A. Carlezon Jr Dynorphin, stress, and depression Brain Res 1314 2010 56 73
51. R.L. Solomon, and J.D. Corbit An opponent-process theory of motivation: I Temporal dynamics of affect Psychol Rev 81 1974 119 145
52. A.M. Barr, A. Markou, and A.G. Phillips A "crash" course on psychostimulant withdrawal as a model of depression Trends Pharmacol Sci 23 2002 475 482 (Pubitemid 35279609)
53. I. Goussakov, E.H. Chartoff, E. Tsvetkov, L.P. Gerety, E.G. Meloni, W.A. Carlezon Jr, and V.Y. Bolshakov LTP in the lateral amygdala during cocaine withdrawal Eur J Neurosci 23 2006 239 250
54. Y. Wang, K. Tang, S. Inan, D. Siebert, U. Holzgrabe, and D.Y.W. Lee Comparison of pharmacological activities of three distinct kappa ligands (salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo J Pharmacol Exp Ther 312 2005 220 230 (Pubitemid 40096472)
55. M. Baggott A survey of Salvia divinorum users Erowid Extracts 6 2004 12 15
56. D. Gonzalez, J. Riba, J.C. Bouso, G. Gomez-Jarabo, and M.J. Barbanoj Pattern of use and subjective effects of Salvia divinorum among recreational users Drug Alcohol Depend 85 2006 157 162 (Pubitemid 44468138)
57. J.M. Hooker, Y. Xu, W. Schiffer, C. Shea, P. Carter, and J.S. Fowler Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans Neuroimage 41 2008 1044 1050
58. J.J. Wagner, G.W. Terman, and C. Chavkin Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus Nature 363 1993 451 454 (Pubitemid 23179391)
59. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 63 (Pubitemid 27446271)
60. J. Bertran-Gonzalez, C. Bosch, M. Maroteaux, M. Matamales, D. Herve, E. Valjent, and J.A. Girault Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol J Neurosci 28 2008 5671 5685
61. H. Steiner, and C.R. Gerfen Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum J Neurosci 13 1993 5066
62. M.R. Bruchas, T. Yang, S. Schreiber, M. Defino, S.C. Kwan, S. Li, and C. Chavkin Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase J Biol Chem 282 2007 29803 29811 (Pubitemid 350035286)